Skip to main content
Clinical Trials/NCT05725525
NCT05725525
Completed
N/A

Feasibility of Internet Delivered Parent Child Interaction Therapy (AI I-PCIT) Real-Time Monitoring of Sleep and Behavior of Children 3-7 Years-Old Receiving Remote PCIT

Mayo Clinic1 site in 1 country5 target enrollmentMarch 2, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Disruptive Behavior
Sponsor
Mayo Clinic
Enrollment
5
Locations
1
Primary Endpoint
How wearing a Garmin watch will help the remote PCIT clinical outcomes
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this study is to learn more about how feasible remote parent child interaction therapy (PCIT) is for children with disruptive behaviors and how to augment treatment with wearable devices.

Detailed Description

Children with disruptive behaviors aged 3-7 will wear a Garmin watch throughout the course of the study (approximately 12 weeks). Artificial Intelligence (AI) will be applied to analyze the vitals provided by the watch to monitor for disruptive behavior. Parent and child will be enrolled in remote PCIT sessions throughout the course of the trial. This study will not require any in person visits, all materials will be mailed to the patients home or sent electronically. The study will analyze how the use of a wearable device throughout PCIT will help increase the benefit to both parent and child as measured by biometrics via Garmin and by questionnaires preformed throughout the trial.

Registry
clinicaltrials.gov
Start Date
March 2, 2023
End Date
December 1, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Magdalena Romanowicz

Principal Investigator

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

How wearing a Garmin watch will help the remote PCIT clinical outcomes

Time Frame: Through study completion, approximately 2 years

Biometrics from the Garmin watch will be analyzed through Fitabase: step count, activity intensity, calories, heartrate, and respirations. This data will be compared throughout the study to see if factors trend down by the end of the trial. This would indicate that the child's behaviors were calmer at the end of the therapy when compared to the beginning.

Evaluating parental acceptance of remote PCIT augmented with a Garmin device

Time Frame: Through study completion, approximately 2 years

At the end of therapy, the parent will receive an emailed survey asking about their opinions of the study technology and how it added to their child's therapy experience.

Number of participants able to wear the Garmin watch throughout remote PCIT

Time Frame: Through study completion, approximately 2 years

The study will measure how often participants are wearing the device by monitoring two platforms that are paired with the watch: Fitabase and Ilumivu. These platforms inform the study team with wear time of the watch by the participant. A measurement of at least 70% of the time will be deemed feasible/acceptable for young patient's ability to wear the watch during therapy.

Secondary Outcomes

  • Evaluating clinical improvement from remote PCIT in regards to sleep(Through study completion, approximately 2 years)
  • Evaluating clinical improvement from remote PCIT in regards to parental reports of behavior accuracy of indirect behavioral measures from wearable devices to parental ratings(Through study completion, approximately 2 years)
  • Evaluating measured sleep data throughout remote PCIT(Through study completion, approximately 2 years)

Study Sites (1)

Loading locations...

Similar Trials